Manager - Regulatory Affairs
Department: Regulatory Affairs
Location: Ambernath
Reports To: Head – Regulatory Affairs
Education: B.Pharm / M.Pharm / M.Sc (Science)
Experience: 15–18 years in API Regulatory Affairs
About PolyPeptide Group
PolyPeptide Group AG and its consolidated subsidiaries (“PolyPeptide”) is a specialized Contract Development & Manufacturing Organization (CDMO) for peptide- and oligonucleotide-based active pharmaceutical ingredients. By supporting its customers mainly in pharma and biotech, it contributes to the health of millions of patients across the world. PolyPeptide serves a fast-growing market, offering products and services from pre-clinical to commercial stages. Its broad portfolio reflects opportunities in drug therapies across multiple areas, with strong exposure to metabolic diseases, including GLP-1.
Founded in 1952, PolyPeptide operates a global network of six GMP-certified facilities across Europe, the U.S., and India. Its shares (SIX: PPGN) are listed on the SIX Swiss Exchange.
Purpose of the Role
To lead and manage global regulatory projects, ensuring successful filing, lifecycle management, and compliance of Drug Master Files (DMFs) across multiple regulatory markets. The role will support the transfer and management of global regulatory activities to the Ambernath regulatory team.
Job Description for Regulatory Affairs Manager
Lead preparation, review, and submission of DMFs for global markets including US, EU (ASMF & CEP), Canada, China, Korea, and emerging regions
Ensure compliance with global regulatory requirements and guidelines including USFDA, EMEA, CEP, and ICH
Develop and execute regulatory filing strategies for synthetic, semi-synthetic, and peptide APIs
Prepare and review deficiency responses in line with regulatory expectations and timelines
Manage lifecycle activities of DMFs including amendments, variations, and post-approval changes across regions
Handle business-critical changes and perform regulatory impact assessments with appropriate implementation strategies
Independently lead regulatory projects and interact with health authorities to drive approvals and resolve queries
Collaborate closely with cross-functional teams and customers to meet regulatory and business objectives
Review technical documents including characterization reports and method validation data
Utilize regulatory systems such as Veeva RIM for documentation and submission management (preferred)
Ensure high levels of coordination, communication, and alignment within internal teams and external stakeholders
Provide strategic and forward-looking regulatory guidance to ensure compliance and competitive positioning
Key Skills & Competencies
Strong knowledge of global regulatory frameworks (US, EU, Canada, Asia & emerging markets)
Expertise in DMF filing and lifecycle management
Strategic thinking and decision-making ability
Excellent technical writing and documentation skills
Strong communication and stakeholder management skills
Ability to work independently and lead regulatory initiatives
Why Join Us at PolyPeptide Group
PolyPeptide Group offers an opportunity to work at the forefront of peptide-based therapeutics, one of the fastest-growing segments in the pharmaceutical industry. As part of a global CDMO, you will contribute to impactful projects, collaborate with international teams, and play a key role in shaping regulatory strategies for life-saving therapies.
- Locations
- Ambernath
Ambernath
Our Core Values
INNOVATION
- We are curious and explore new ways.
- We are also ambitious and find solutions.
EXCELLENCE
- We have a strong technical knowledge, and we deliver results
- We lead quality in everything we do
- We are adaptable and customer focused
TRUST
- We believe in teamwork and collaboration.
- We lead by example and accept responsibility
- We are transparent and we show integrity.
About PolyPeptide Group
PolyPeptide Group AG and its consolidated subsidiaries (“PolyPeptide”) is a focused Contract Development & Manufacturing Organization (CDMO) for peptide- and oligonucleotide-based active pharmaceutical ingredients. By supporting its customers mainly in pharma and biotech, it contributes to the health of millions of patients across the world.
PolyPeptide offers products and services from pre-clinical through to commercial stages, including generics. Its active custom projects pipeline reflects the opportunities from novel drug therapies in development to fight both widespread and rare diseases. Dating back to 1952, PolyPeptide today runs a global network of six cGMP-certified facilities in Europe, the U.S. and India. PolyPeptide Group AG’s shares (SIX: PPGN) are listed on SIX Swiss Exchange.